CDC-Authored Genomics and Precision Health Publications Database
Last data update: Jan 19, 2021. (Total: 3115 publications since 2011)
| Query Trace: all>>Scott D Grosse[CDC Author] |
|---|
| Health and economic outcomes of newborn screening for infantile-onset Pompe disease. John S Richardson, Alex R Kemper, Scott D Grosse, Wendy K K Lam, Angela M Rose, Ayesha Ahmad, Achamyeleh Gebremariam, and Lisa A Prosser Genetics in medicine : official journal of the American College of Medical Genetics 2020 Dec |
| Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017. Marci K Sontag, Careema Yusuf, Scott D Grosse, Sari Edelman, Joshua I Miller, Sarah McKasson, Yvonne Kellar-Guenther, Marcus Gaffney, Cynthia F Hinton, Carla Cuthbert, Sikha Singh, Jelili Ojodu, and Stuart K Shapira MMWR. Morbidity and mortality weekly report 2020 Sep 69(36) 1265-1268 |
| Ensuring the Life-Span Benefits of Newborn Screening. Alex R Kemper, Coleen A Boyle, Jeffrey P Brosco, and Scott D Grosse Pediatrics 2019 Nov |
| Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease. Lisa A Prosser, K K Lam, Scott D Grosse, Mia Casale, and Alex R Kemper MDM policy & practice 3(1) |
| Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value? Scott D Grosse, and Lauge Farnaes Genetics in medicine : official journal of the American College of Medical Genetics 2018 Aug |
| Is universal tumor testing for Lynch syndrome cost-effective? It depends! Scott D Grosse Genetics in medicine : official journal of the American College of Medical Genetics 2018 May |
| Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations. Lisa B Feng, Scott D Grosse, Ridgely Fisk Green, Aliza K Fink, and Gregory S Sawicki Health affairs (Project Hope) 2018 May 37(5) 773-779 |
| In Reference to: "Cost and Utility of Thrombophilia Testing". Brygida Berse, Julie A Lynch, Scott Bowen, and Scott D Grosse Journal of hospital medicine 2017 Sep 12(9) 783 |
| Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes. Scott D Grosse, Lyle C Gurrin, Nadine A Bertalli, and Katrina J Allen Genetics in medicine : official journal of the American College of Medical Genetics 2018 Apr 20(4) 383-389 |
| Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1. Scott D Grosse, Wendy K K Lam, Lisa D Wiggins, and Alex R Kemper Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(9) 975-982 |
| The need for a next-generation public health response to rare diseases. Rodolfo Valdez, Scott D Grosse, and Muin J Khoury Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct |
| Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testing. Scott D Grosse, and Muin J Khoury Genetics in medicine : official journal of the American College of Medical Genetics 2016 18(10) 963-5 |
| Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation. Alex R Kemper, Jeffrey Brosco, Anne Marie Comeau, Nancy S Green, Scott D Grosse, Elizabeth Jones, Jennifer M Kwon, Wendy K K Lam, Jelili Ojodu, Lisa A Prosser, and Susan Tanksley Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(1) 121-126 |
| Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. Yao Ding, John D Thompson, Lisa Kobrynski, Jelili Ojodu, Guisou Zarbalian, and Scott D Grosse The Journal of pediatrics 2016 Feb |
| The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Maria D Karaceper, Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B Kronick, Steven Hawken, Christine Davies, Marni Brownell, Linda Dodds, Annette Feigenbaum, Deshayne B Fell, Scott D Grosse, Astrid Guttmann, Anne-Marie Laberge, Aizeddin Mhanni, Fiona A Miller, John J Mitchell, Meranda Nakhla, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Brenda J Wilson, Beth K Potter, and Orphanet journal of rare diseases 2016 Feb 1112 |
| Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis. Scott D Grosse Healthcare (Basel, Switzerland) 2015 3(4) 1133-57 |
| Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium. Frédéric B Piel, Thomas V Adamkiewicz, Djesika Amendah, Thomas N Williams, Sunetra Gupta, and Scott D Grosse Genetics in medicine : official journal of the American College of Medical Genetics 2015 Dec |
| When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives. Scott D Grosse Healthcare (Basel, Switzerland) 2015 3(4) 860-78 |
| The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Scott D Grosse, Glenn E Palomaki, Mercy Mvundura, and Heather Hampel Genet. Med. 2015 Jun 17(6) 510-1 |
| Universal state newborn screening programs can reduce health disparities. Jeffrey P Brosco, Scott D Grosse, and Lainie Friedman Ross JAMA Pediatr 2015 Jan 169(1) 7-8 |
| Mortality of New York children with sickle cell disease identified through newborn screening. Ying Wang, Gang Liu, Michele Caggana, Joseph Kennedy, Regina Zimmerman, Suzette O Oyeku, Ellen M Werner, Althea M Grant, Nancy S Green, and Scott D Grosse Genet. Med. 2015 Jun 17(6) 452-9 |
| Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility. Scott D Grosse Genet. Med. 2014 Mar 16(3) 225-7 |
| Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most? Wolf H Rogowski, Scott D Grosse, Jörg Schmidtke, and Georg Marckmann Eur. J. Hum. Genet. 2014 Jan 22(1) 25-31 |
| The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Scott D Grosse, Sheree L Boulet, Althea M Grant, Mary M Hulihan, and Marie E Faughnan Genet. Med. 2014 Jan 16(1) 33-9 |
| Modeling uncertain outcomes of genetic testing: factor V Leiden mutation and pregnant women. Scott D Grosse, and Aaron B Caughey Genet. Med. 2013 May 15(5) 335-7 |
| Sickle cell disease incidence among newborns in New York State by maternal race/ethnicity and nativity. Ying Wang, Joseph Kennedy, Michele Caggana, Regina Zimmerman, Sanil Thomas, John Berninger, Katharine Harris, Nancy S Green, Suzette Oyeku, Mary Hulihan, Althea M Grant, and Scott D Grosse Genetics in medicine : official journal of the American College of Medical Genetics 2013 Mar 15(3) 222-8 |
| Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Lisa A Prosser, Scott D Grosse, Alex R Kemper, Beth A Tarini, and James M Perrin Genet. Med. 2012 Apr 5. |
| Iron overload: what is the role of public health? Mary M Hulihan, Cindy A Sayers, Scott D Grosse, Cheryl Garrison, and Althea M Grant Am J Prev Med 2011 Dec 41(6 Suppl 4) S422-7 |
| Sickle cell disease in Africa: a neglected cause of early childhood mortality. Scott D Grosse, Isaac Odame, Hani K Atrash, Djesika D Amendah, Frédéric B Piel, and Thomas N Williams Am J Prev Med 2011 Dec 41(6 Suppl 4) S398-405 |
| A public health framework for rare blood disorders. Scott D Grosse, Andra H James, Michele A Lloyd-Puryear, and Hani K Atrash Am J Prev Med 2011 Dec 41(6 Suppl 4) S319-23 |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: